The correlation between regulatory conditions and antibiotic consumption within the WHO European Region

Tanja Mueller, Per Olof Östergren

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background In a global perspective, bacterial infections are still a major cause of morbidity and mortality; therefore, effective antibiotics are needed. However, the emergence of antibiotic resistance due to irrational use has now become a serious public health problem. Hence, the objective of this study was to analyse the association of regulatory aspects with antibiotic consumption. Methods A data set representing 20 countries throughout the WHO European Region was chosen based on data availability so as to analyse the correlation between specific regulatory conditions and antibiotic consumption, using total consumption data for 2011 and information about national provisions regarding rational use of medicines. Linear regression models were designed in order to evaluate individual aspects as well as the overall level of regulation. Results A high level of regulation, assessed by an overall index, was significantly correlated with lower antibiotic consumption; however, of all individual items analysed, only the presence of Standard Treatment Guidelines for hospital care as well as paediatric conditions, the non-availability of antibiotics without a prescription, and the existence of training modules for pharmacists covering rational use of medicines gave significant results, i.e. lower use of antibiotics, when regarded in isolation. Conclusion Although national regulatory conditions intended to foster rational use of antibiotics seem to be correlated with antibiotic consumption, this association is potentially influenced by a wide range of contextual aspects.

LanguageEnglish
Pages882-889
Number of pages8
JournalHealth Policy
Volume120
Issue number8
Early online date12 Jul 2016
DOIs
Publication statusPublished - 1 Aug 2016

Fingerprint

Anti-Bacterial Agents
Linear Models
Microbial Drug Resistance
Pharmacists
Bacterial Infections
Prescriptions
Public Health
Guidelines
Pediatrics
Morbidity
Mortality

Keywords

  • antibiotic resistance
  • antibiotic stewardship
  • antibiotics
  • rational use of medicines

Cite this

@article{fbb8395e44524409a5914c12698b46b8,
title = "The correlation between regulatory conditions and antibiotic consumption within the WHO European Region",
abstract = "Background In a global perspective, bacterial infections are still a major cause of morbidity and mortality; therefore, effective antibiotics are needed. However, the emergence of antibiotic resistance due to irrational use has now become a serious public health problem. Hence, the objective of this study was to analyse the association of regulatory aspects with antibiotic consumption. Methods A data set representing 20 countries throughout the WHO European Region was chosen based on data availability so as to analyse the correlation between specific regulatory conditions and antibiotic consumption, using total consumption data for 2011 and information about national provisions regarding rational use of medicines. Linear regression models were designed in order to evaluate individual aspects as well as the overall level of regulation. Results A high level of regulation, assessed by an overall index, was significantly correlated with lower antibiotic consumption; however, of all individual items analysed, only the presence of Standard Treatment Guidelines for hospital care as well as paediatric conditions, the non-availability of antibiotics without a prescription, and the existence of training modules for pharmacists covering rational use of medicines gave significant results, i.e. lower use of antibiotics, when regarded in isolation. Conclusion Although national regulatory conditions intended to foster rational use of antibiotics seem to be correlated with antibiotic consumption, this association is potentially influenced by a wide range of contextual aspects.",
keywords = "antibiotic resistance, antibiotic stewardship, antibiotics, rational use of medicines",
author = "Tanja Mueller and {\"O}stergren, {Per Olof}",
year = "2016",
month = "8",
day = "1",
doi = "10.1016/j.healthpol.2016.07.004",
language = "English",
volume = "120",
pages = "882--889",
journal = "Health Policy",
issn = "0168-8510",
number = "8",

}

The correlation between regulatory conditions and antibiotic consumption within the WHO European Region. / Mueller, Tanja; Östergren, Per Olof.

In: Health Policy, Vol. 120, No. 8, 01.08.2016, p. 882-889.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The correlation between regulatory conditions and antibiotic consumption within the WHO European Region

AU - Mueller, Tanja

AU - Östergren, Per Olof

PY - 2016/8/1

Y1 - 2016/8/1

N2 - Background In a global perspective, bacterial infections are still a major cause of morbidity and mortality; therefore, effective antibiotics are needed. However, the emergence of antibiotic resistance due to irrational use has now become a serious public health problem. Hence, the objective of this study was to analyse the association of regulatory aspects with antibiotic consumption. Methods A data set representing 20 countries throughout the WHO European Region was chosen based on data availability so as to analyse the correlation between specific regulatory conditions and antibiotic consumption, using total consumption data for 2011 and information about national provisions regarding rational use of medicines. Linear regression models were designed in order to evaluate individual aspects as well as the overall level of regulation. Results A high level of regulation, assessed by an overall index, was significantly correlated with lower antibiotic consumption; however, of all individual items analysed, only the presence of Standard Treatment Guidelines for hospital care as well as paediatric conditions, the non-availability of antibiotics without a prescription, and the existence of training modules for pharmacists covering rational use of medicines gave significant results, i.e. lower use of antibiotics, when regarded in isolation. Conclusion Although national regulatory conditions intended to foster rational use of antibiotics seem to be correlated with antibiotic consumption, this association is potentially influenced by a wide range of contextual aspects.

AB - Background In a global perspective, bacterial infections are still a major cause of morbidity and mortality; therefore, effective antibiotics are needed. However, the emergence of antibiotic resistance due to irrational use has now become a serious public health problem. Hence, the objective of this study was to analyse the association of regulatory aspects with antibiotic consumption. Methods A data set representing 20 countries throughout the WHO European Region was chosen based on data availability so as to analyse the correlation between specific regulatory conditions and antibiotic consumption, using total consumption data for 2011 and information about national provisions regarding rational use of medicines. Linear regression models were designed in order to evaluate individual aspects as well as the overall level of regulation. Results A high level of regulation, assessed by an overall index, was significantly correlated with lower antibiotic consumption; however, of all individual items analysed, only the presence of Standard Treatment Guidelines for hospital care as well as paediatric conditions, the non-availability of antibiotics without a prescription, and the existence of training modules for pharmacists covering rational use of medicines gave significant results, i.e. lower use of antibiotics, when regarded in isolation. Conclusion Although national regulatory conditions intended to foster rational use of antibiotics seem to be correlated with antibiotic consumption, this association is potentially influenced by a wide range of contextual aspects.

KW - antibiotic resistance

KW - antibiotic stewardship

KW - antibiotics

KW - rational use of medicines

UR - http://www.scopus.com/inward/record.url?scp=84979079557&partnerID=8YFLogxK

U2 - 10.1016/j.healthpol.2016.07.004

DO - 10.1016/j.healthpol.2016.07.004

M3 - Article

VL - 120

SP - 882

EP - 889

JO - Health Policy

T2 - Health Policy

JF - Health Policy

SN - 0168-8510

IS - 8

ER -